155 related articles for article (PubMed ID: 25001531)
1. Apoptin towards safe and efficient anticancer therapies.
Backendorf C; Noteborn MH
Adv Exp Med Biol; 2014; 818():39-59. PubMed ID: 25001531
[TBL] [Abstract][Full Text] [Related]
2. PTD4-apoptin protein therapy inhibits tumor growth in vivo.
Sun J; Yan Y; Wang XT; Liu XW; Peng DJ; Wang M; Tian J; Zong YQ; Zhang YH; Noteborn MH; Qu S
Int J Cancer; 2009 Jun; 124(12):2973-81. PubMed ID: 19326452
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice.
Ma JL; Han SX; Zhao J; Zhang D; Wang L; Li YD; Zhu Q
Int J Oncol; 2012 Sep; 41(3):1013-20. PubMed ID: 22767069
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
5. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo.
Jin JL; Gong J; Yin TJ; Lu YJ; Xia JJ; Xie YY; Di Y; He L; Guo JL; Sun J; Noteborn MH; Qu S
Eur J Pharmacol; 2011 Mar; 654(1):17-25. PubMed ID: 21184754
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
7. Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.
Zhang KJ; Qian J; Wang SB; Yang Y
J Biomed Sci; 2012 Feb; 19(1):20. PubMed ID: 22321574
[TBL] [Abstract][Full Text] [Related]
8. Secretory Transactivating Transcription-apoptin fusion protein induces apoptosis in hepatocellular carcinoma HepG2 cells.
Han SX; Ma JL; Lv Y; Huang C; Liang HH; Duan KM
World J Gastroenterol; 2008 Jun; 14(23):3642-9. PubMed ID: 18595131
[TBL] [Abstract][Full Text] [Related]
9. PTD4-apoptin induces Bcl-2-insensitive apoptosis in human cervical carcinoma in vitro and in vivo.
Liu XW; Yuan P; Tian J; Li LJ; Wang Y; Huang SC; Liu L; Backendorf C; Noteborn MH; Sun J
Anticancer Drugs; 2016 Nov; 27(10):979-87. PubMed ID: 27548349
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo.
Pan Y; Fang L; Fan H; Luo R; Zhao Q; Chen H; Xiao S
Int J Cancer; 2010 Jun; 126(11):2741-51. PubMed ID: 19824041
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitro.
Li X; Jin N; Mi Z; Lian H; Sun L; Li X; Zheng H
Int J Cancer; 2006 Dec; 119(12):2948-57. PubMed ID: 17036330
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.
Yuan L; Zhao H; Zhang L; Liu X
Tumour Biol; 2013 Oct; 34(5):3027-34. PubMed ID: 23907578
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor.
Peng DJ; Sun J; Wang YZ; Tian J; Zhang YH; Noteborn MH; Qu S
Cancer Gene Ther; 2007 Jan; 14(1):66-73. PubMed ID: 16874360
[TBL] [Abstract][Full Text] [Related]
14. Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma.
Zhang M; Wang J; Li C; Hu N; Wang K; Ji H; He D; Quan C; Li X; Jin N; Li Y
Int J Oncol; 2013 Mar; 42(3):1052-60. PubMed ID: 23338489
[TBL] [Abstract][Full Text] [Related]
15. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.
Pietersen AM; van der Eb MM; Rademaker HJ; van den Wollenberg DJ; Rabelink MJ; Kuppen PJ; van Dierendonck JH; van Ormondt H; Masman D; van de Velde CJ; van der Eb AJ; Hoeben RC; Noteborn MH
Gene Ther; 1999 May; 6(5):882-92. PubMed ID: 10505114
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of apoptin expressed by the dual cancer-specific oncolytic adenovirus - a review.
Fang JB; Zhu GZ; Zhu YL; Li YQ; Shang C; Bai B; Jin NY; Li X
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11334-11343. PubMed ID: 33215453
[TBL] [Abstract][Full Text] [Related]
17. Apoptin enhances the oncolytic properties of Newcastle disease virus.
Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
[TBL] [Abstract][Full Text] [Related]
18. The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cells.
Zhao J; Han SX; Ma JL; Ying X; Liu P; Li J; Wang L; Zhang Y; Ma J; Zhang L; Zhu Q
Oncol Rep; 2013 Jul; 30(1):253-9. PubMed ID: 23619525
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus.
Qi Y; Guo H; Hu N; He D; Zhang S; Chu Y; Huang Y; Li X; Sun L; Jin N
Toxicol Appl Pharmacol; 2014 Oct; 280(2):362-9. PubMed ID: 25151223
[TBL] [Abstract][Full Text] [Related]
20. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation.
Backendorf C; Visser AE; de Boer AG; Zimmerman R; Visser M; Voskamp P; Zhang YH; Noteborn M
Annu Rev Pharmacol Toxicol; 2008; 48():143-69. PubMed ID: 17848136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
